Clinical Trials
Pegylated Interferon Alfa-2b
Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in Adult Essential Thrombocythemia ClinicalTrials.gov ID NCT05395507 Sponsor Institute of Hematology & Blood Diseases Hospital, China
Month: March 2025
Clinical Trials
Recombinant Interleukin-15
Recombinant Interleukin-15 in Combination With Checkpoint Inhibitors Nivolumab and Ipilimumab in People With Refractory Cancers ClinicalTrials.gov ID NCT03388632 Sponsor National Cancer Institute (NCI) Information provided by National Institutes of Health Clinical Center (CC) (National Cancer Institute (NCI)) (Responsible Party)
Clinical Trials
Role of IL-5R Signaling
Role of IL-5R Signaling in Non-eosinophil Upper Airway Cells in CRSwNP (RECAP-5) ClinicalTrials.gov ID NCT05672030 Sponsor Brigham and Women’s Hospital Information provided by Tanya Laidlaw, MD, Brigham and Women’s Hospital (Responsible Party)
Special Article of Interest
Challenges and Opportunities of Conducting High-Quality Research in Cytokine Biology and Immunology in Low- and Middle-Income Countries
The following perspective is by ICIS Member, Javier Mora, Ph.D., University of Costa Rica, Faculty of Microbiology. We welcome your comments and feedback, either to Prof. Mora (javierfrancisco.mora @ ucr.ac.cr) directly or to the ICIS Managing Director, Stephanie Flores (sflores @ cytokinesociety.org). Research in cytokines and immunology plays a pivotal [READ MORE]
Member Highlights
Member Highlight: Meet Kim Good-Jacobson, PhD
The following interview was conducted by Signals+ Editor Maialen Sebastian-delaCruz, Ph.D. Connect with her on LinkedIn. My lab in Australia works on understanding how humoral memory is formed, and how this goes awry in chronic infection. I’m excited to be able to learn and make new collaborations from joining the Cytokine Society, so [READ MORE]